National Academies Press: OpenBook

Tuberculosis in the Workplace (2001)

Chapter: Appendix G Recommendations of the Institute of Medicine Committee

« Previous: Appendix F Respiratory Protection and Control of Tuberculosis in Health Care and Other Facilities
Suggested Citation:"Appendix G Recommendations of the Institute of Medicine Committee." Institute of Medicine. 2001. Tuberculosis in the Workplace. Washington, DC: The National Academies Press. doi: 10.17226/10045.
×

G
Recommendations of the Institute of Medicine Committee on Eliminating Tuberculosis in the United States1

Recommendation 3.1 To permanently interrupt the transmission of tuberculosis and prevent the emergence of multidrug-resistant tuberculosis, the committee recommends that

  • All states have health regulations that mandate completion of therapy (treatment to cure) for all patients with active tuberculosis.

  • All treatment be administered in the context of patient-centered programs that are based on individual patient characteristics. Such programs must be the standard of care for patients with tuberculosis in all settings.

Recommendation 3.2 To ensure the most efficient application of existing resources, the committee recommends that

  • New program standards be developed and used by CDC [Centers for Disease Control and Prevention] and state and local health departments to evaluate program performance.

  • Standardized, flexible case management systems be developed to provide the information needed for the evaluation measurements. These systems should be integrated with existing case management systems and other automated public health data systems whenever possible.

1  

Institute of Medicine. Ending Neglect: The Elimination of Tuberculosis in the United States Geiter L, ed. Washington DC: National Academy Press, 2000, pp. 6–12.

Suggested Citation:"Appendix G Recommendations of the Institute of Medicine Committee." Institute of Medicine. 2001. Tuberculosis in the Workplace. Washington, DC: The National Academies Press. doi: 10.17226/10045.
×

Recommendation 3.3 To make further progress toward the elimination of tuberculosis in regions of the country experiencing low rates of disease, the committee recommends that

  • Tuberculosis elimination activities be regionalized through a combination of federal and multistate initiatives to provide better access to and more efficient utilization of clinical, epidemiological, and other technical services.

  • Protocols and action plans be developed jointly by CDC and the states for use by state and local health departments to enable planning for the availability of adequate resources.

  • State and local health departments develop case management plans to ensure a uniform high quality of care for patients with tuberculosis and tuberculosis infection in their jurisdictions.

Recommendation 3.4 To maintain quality in tuberculosis care and control services in an era of increased use of managed care systems and privatization of services, the committee recommends that

  • When it is determined that tuberculosis diagnosis and treatment services can be provided more efficiently outside of the public health department, the delivery of such services be governed by well-designed contracts that specify performance measures and responsibilities.

  • Federal categorical funding for tuberculosis control be retained. Funding at the local level should provide sufficient dedicated resources for tuberculosis control but should be structured to provide maximum flexibility and efficiency.

  • Both public and private health insurance programs be billed for tuberculosis diagnostic and treatment services whenever possible, but tuberculosis services should never be denied due to a patient’s inability to make a co-payment.

Recommendation 3.5 To promote a well-trained medical (in a broad sense) workforce and educated public, the committee recommends that

  • The Strategic Plan for Tuberculosis Training and Education, which contains the blueprint that addresses the training and educational needs for tuberculosis control, be fully funded.

  • Programs for the education of patients with tuberculosis be developed and funded.

  • Funding be provided for government, academic, and nongovernmental agencies to work in collaboration with international partners to develop training and educational materials.

Recommendation 4.1 To limit the spread of tuberculosis from infectious patients to their contacts, the committee recommends that more

Suggested Citation:"Appendix G Recommendations of the Institute of Medicine Committee." Institute of Medicine. 2001. Tuberculosis in the Workplace. Washington, DC: The National Academies Press. doi: 10.17226/10045.
×

effective methodologies for the identification of persons with recently acquired tuberculosis infection, especially persons exposed to patients with new cases of tuberculosis, be developed and efforts be increased to evaluate appropriately and treat latent infection in all persons who meet the criteria for treatment for such infections.

Recommendation 4.2 To prevent the development of tuberculosis among individuals with latent tuberculosis infection, the committee recommends that

  • Tuberculin skin testing be required as part of the medical evaluation for immigrant visa applicants from countries with high rates of tuberculosis, a Class B4 immigration waiver designation be created for persons with normal chest radiographs and positive tuberculin skin tests, and all tuberculin-positive Class B immigrants be required to undergo an evaluation for tuberculosis and, when indicated, complete an approved course of treatment for latent infection before receiving a permanent residency card (“green card”). Implementation should be in a step wise fashion, and pilot programs should evaluate strategies and assess costs.

  • Tuberculin testing be required of all inmates of correctional facilities and completion of an approved course of treatment, when indicated, be required, with referral to the appropriate public health agency for all inmates released before completion of treatment.

  • Programs of targeted tuberculin skin testing and treatment of latent infection be increased for high-incidence groups, such as HlV-infected individuals, undocumented immigrants, homeless individuals, and intravenous drug abusers, as determined by local epidemiological circumstances.

Recommendation 5.1 To advance the development of tuberculosis vaccines, the committee recommends that the plans outlined in the Blueprint for Tuberculosis Vaccine Development, published by NIH [National Institutes of Health] in 1998, be fully implemented.

Recommendation 5.2 To advance the development of diagnostic tests and new drugs for both latent infection and active disease, action plans should be developed and implemented. CDC should then exploit its expertise in population-based research to evaluate and define the role of promising products.

Recommendation 5.3 To promote better understanding of patient and provider nonadherence with tuberculosis treatment recommendations and guidelines, a plan for a behavioral and social science research agenda should be developed and implemented.

Suggested Citation:"Appendix G Recommendations of the Institute of Medicine Committee." Institute of Medicine. 2001. Tuberculosis in the Workplace. Washington, DC: The National Academies Press. doi: 10.17226/10045.
×

Recommendation 5.4 To encourage private-sector product development, the global market for tuberculosis diagnostic tests, drugs, and vaccines should be better characterized and access to these markets for these new products should be facilitated.

Recommendation 5.5 To define the applicability of any new tools to the international arena and facilitate their development, the U.S. Agency for International Development (AID), NIH, and CDC should build upon international relationships and expertise to conduct research.

Recommendation 6.1 To decrease the number of foreign-born individuals with tuberculosis in the United States, to minimize the spread and impact of multidrug-resistant tuberculosis, and to improve global health, the committee recommends that

  • The United States expand and strengthen its role in global tuberculosis control efforts, contributing to these efforts in a substantial manner through bilateral and multilateral international efforts.

  • The United States contribute to global tuberculosis control efforts through targeted use of financial, technical, and human resources and research, all guided by a carefully considered strategic plan.

  • The United States work in close coordination with other government and international agencies. In particular, the United States should continue its active role in and support of the Stop TB Initiative.

  • AID, CDC, and NIH should jointly develop and publish strategic plans to guide U.S. involvement in global tuberculosis control efforts.

Recommendation 7.1 To build public support and sustain public interest and commitment to the elimination of tuberculosis, the committee recommends that CDC significantly increase resources for activities to secure and sustain public understanding and support for tuberculosis elimination efforts at the national, state, and local levels, including programs to increase knowledge among targeted groups of the general public.

Recommendation 7.2 To increase the effectiveness of mobilization efforts the committee recommends that the National Coalition for the Elimination of Tuberculosis continue to provide leadership and oversight and that CDC continue to work in collaboration with the coalition to secure the support and participation of nontraditional public health partners, ensure the development of state and local coalitions, and evaluate public understanding and support for tuberculosis elimination efforts with the assistance of public opinion research experts.

Suggested Citation:"Appendix G Recommendations of the Institute of Medicine Committee." Institute of Medicine. 2001. Tuberculosis in the Workplace. Washington, DC: The National Academies Press. doi: 10.17226/10045.
×

Recommendation 7.3 To assess the impacts of these recommendations and to measure progress toward accomplishing the elimination of tuberculosis, the committee recommends that, 3 years after the publication of this report and periodically thereafter, the Office of the Secretary of Health and Human Services conduct an evaluation of the actions taken in response to the recommendations in this report.

Suggested Citation:"Appendix G Recommendations of the Institute of Medicine Committee." Institute of Medicine. 2001. Tuberculosis in the Workplace. Washington, DC: The National Academies Press. doi: 10.17226/10045.
×
Page 309
Suggested Citation:"Appendix G Recommendations of the Institute of Medicine Committee." Institute of Medicine. 2001. Tuberculosis in the Workplace. Washington, DC: The National Academies Press. doi: 10.17226/10045.
×
Page 310
Suggested Citation:"Appendix G Recommendations of the Institute of Medicine Committee." Institute of Medicine. 2001. Tuberculosis in the Workplace. Washington, DC: The National Academies Press. doi: 10.17226/10045.
×
Page 311
Suggested Citation:"Appendix G Recommendations of the Institute of Medicine Committee." Institute of Medicine. 2001. Tuberculosis in the Workplace. Washington, DC: The National Academies Press. doi: 10.17226/10045.
×
Page 312
Suggested Citation:"Appendix G Recommendations of the Institute of Medicine Committee." Institute of Medicine. 2001. Tuberculosis in the Workplace. Washington, DC: The National Academies Press. doi: 10.17226/10045.
×
Page 313
Next: Appendix H Committee Biographies »
Tuberculosis in the Workplace Get This Book
×
Buy Paperback | $67.00 Buy Ebook | $54.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Before effective treatments were introduced in the 1950s, tuberculosis was a leading cause of death and disability in the United States. Health care workers were at particular risk. Although the occupational risk of tuberculosis has been declining in recent years, this new book from the Institute of Medicine concludes that vigilance in tuberculosis control is still needed in workplaces and communities. Tuberculosis in the Workplace reviews evidence about the effectiveness of control measures—such as those recommended by the Centers for Disease Control and Prevention—intended to prevent transmission of tuberculosis in health care and other workplaces. It discusses whether proposed regulations from the Occupational Safety and Health Administration would likely increase or sustain compliance with effective control measures and would allow adequate flexibility to adapt measures to the degree of risk facing workers.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!